Randomized controlled trial of mineralocorticoid receptor blockade in children with chronic kidney allograft nephropathy
Clinical Journal of the American Society of Nephrology Aug 30, 2017
Medeiros M, et al. – The effect of long–term eplerenone administration on renal allograft function in children with biopsy–proven chronic allograft nephropathy (CAN) was examined in the translational study. Findings of this study encouraged testing the potential benefit of mineralocorticoid receptor blockade (MRB) in this pediatric population. However, this study found to be underpowered to provide definitive evidence that long–term eplerenone administration attenuated the progression of CAN in pediatric transplant patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries